|
Market Cap (21-May) $526,472,800 (439th) |
Close (30-Jun) $4.40 |
Volume (30-Jun) 565,229 |
Shortsold (5-May) 2,410,503 (2.97%) (86th) |
|
52w High $7.31 |
52w Low $3.74 |
P/E 285.71 |
EPS -1.56 |
MYX released this announcement to the ASX on 14 May 2021, 16:09. The announcement is not marked as price sensitive, and is 17 page(s) in length and 1.21MB in size.
You can view all announcements from MYX and see how they appear on a price chart on the announcements page.
At the date of this announcement, MYX was 1.559% short sold according to ASIC data. It was ranked the 125th most shorted stock on the ASX. It is now ranked as the 86th most shorted stock on the ASX with 2.967% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from MYX | |
|---|---|
| Notification of cessation of securities - MYX | 30 June 2023, 16:11 |
| Update - Notification of buy-back - MYX | 30 June 2023, 8:19 |
| Update - Notification of buy-back - MYX | 29 June 2023, 8:20 |
| Becoming a substantial holder | 14 May 2021, 16:09 |
| Appendix 2A and Notice under ASX Listing Rule 3.10A | 13 May 2021, 16:40 |
| Change in substantial holding | 20 April 2021, 17:41 |
| FDA approval of novel oral contraceptive NEXTSTELLIS | 16 April 2021, 8:24 |
You must be logged in to post a reply.
Mayne Pharma Group 